Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoporosis: trends and intervention.

Angela M Inzerillo1, Mone Zaidi

  • 1Mount Sinai Bone Program, Department of Medicine, Division of Endocrinology, Mount Sinai School of Medicine, One East 100th Street, New York, NY 10029, USA.

The Mount Sinai Journal of Medicine, New York
|October 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Linezolid Acts as a Selective Inhibitor of the JAK2 <sup>V617F</sup> Mutation.

bioRxiv : the preprint server for biology·2026
Same author

From discovery to therapeutic development of monoclonal antibodies.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Erythroferrone Modulates Osteoblast-Osteoclast Crosstalk During Bone Remodeling.

bioRxiv : the preprint server for biology·2026
Same author

Neuroendocrine and neural control of bone mass in health and disease.

The Journal of clinical investigation·2026
Same author

Erythroferrone derived from osteoblasts regulates stress erythropoiesis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Atlas of GLP-1 expression in the mouse brain: Neuroanatomical basis for metabolic and psychiatric effects.

Brain medicine : from neurons to behavior and better health·2026

Osteoporosis, a skeletal disorder causing bone loss, is a major health concern in the elderly. Advances in understanding, screening, and treating osteoporosis are making it largely preventable.

Area of Science:

  • Gerontology
  • Orthopedics
  • Endocrinology

Background:

  • Osteoporosis is a skeletal disorder characterized by compromised bone strength due to reduced bone density and quality.
  • It is a leading cause of morbidity and functional loss in the elderly population.
  • Distinguishing osteoporosis from normal skeletal aging presents a clinical challenge due to a prolonged asymptomatic phase and overlapping diagnostic criteria.

Purpose of the Study:

  • To review the mechanisms underlying osteoporosis.
  • To discuss current and emerging modalities for screening and diagnosing osteoporosis.
  • To explore existing and experimental therapeutic approaches for managing osteoporosis.

Main Methods:

  • Review of scientific literature on osteoporosis mechanisms.

Related Experiment Videos

  • Analysis of diagnostic procedures and bone mineral density measurement technologies.
  • Examination of current and investigational therapeutic strategies.

    • Main Results:

    • Significant research efforts and technological advancements are enhancing the understanding and management of osteoporosis.
    • Current diagnostic tools can identify fracture risk, but overlap exists with non-fracture groups.
    • Therapeutic modalities are advancing, with promising experimental treatments under development.

    Conclusions:

    • Osteoporosis management has advanced, making it largely a preventable disease.
    • Continued research is crucial to refine diagnostic thresholds and therapeutic interventions.
    • A comprehensive understanding of mechanisms, diagnostics, and therapeutics is key to combating osteoporosis.